- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03408600
Physiologic Indicators for Prognosis in Abdominal Sepsis Study (PIPAS)
Physiologic Indicators for Prognosis in Abdominal Sepsis (PIPAS) Study
Early detection and timely therapeutic intervention can improve the prognosis of patients with sepsis. However, early diagnosis of sepsis can be difficult; because determining which patients presenting with signs of infection during an initial evaluation, do currently have, or will later develop a more serious illness is not easy.
Physiological deterioration often precedes clinical deterioration as patients develop critical illness. In this study, the investigators aim to evaluate vital signs in a global cohort of patients with acute secondary peritonitis, determining which parameters are statistically significant to predict in-hospital mortality and ICU admission.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study will be a worldwide multicenter observational study. The study will include patients admitted in the surgical department with acute peritonitis during a four-month study period (February 1, 2018 - May 31, 2018).
The study will not attempt to change or modify the clinical practice of the participating physicians: neither informed consent or formal approval by local Ethics Committee will be required because of the purely observational nature of the study.
The study will be monitored by the principal investigator, which will investigate and verify missing or unclear data submitted to a central database.
The study protocol has been approved by the board of the WSES and the study will be conducted under its supervision. The board of the WSES grants the proper ethical conduct of the study.
The data collection will be anonymous, as well as the name of the patients or hospital will be not collected in the website. Every hospital will continue following their ethical standards and local rules. The list of the submitted cases will not be recognized by investigators and linked to the submitting hospital. Individual researchers will take personal responsibility of data collection of this study.
In each center, the coordinator will collect and fill the data in an online case report system. These data included the following:
- Patient and disease characteristics
- Diagnostic profiles
- Treatment profiles
- Post-operative course
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Bologna, Italy, 40139
- WSES
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Clinical diagnosis of acute (secondary) localized or diffuse peritonitis.
Exclusion Criteria:
- Clinical diagnosis of acute pancreatitis
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Respiratory rate predicting mortality in patients with acute secondary peritonitis at admission
Time Frame: 24 weeks
|
Respiratory rate (breaths/min);
|
24 weeks
|
Blood oxygen saturation level predicting mortality in patients with acute secondary peritonitis at admission
Time Frame: 24 weeks
|
Blood oxygen saturation level (SpO2) (%) in air
|
24 weeks
|
Core temperature predicting mortality in patients with acute secondary peritonitis at admission
Time Frame: 24 weeks
|
Core temperature (°C);
|
24 weeks
|
Systolic blood pressure predicting mortality in patients with acute secondary peritonitis at admission
Time Frame: 24 weeks
|
Systolic blood pressure (mmHg);
|
24 weeks
|
Hearth rate predicting mortality in patients with acute secondary peritonitis at admission
Time Frame: 24 weeks
|
Hearth rate (bpm);
|
24 weeks
|
Responsiveness predicting mortality in patients with acute secondary peritonitis at admission
Time Frame: 24 weeks
|
Alert/verbal/painful/unresponsive (AVPU) responsiveness scale;
|
24 weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- WSES/4
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abdominal Sepsis
-
Tianjin Medical University Cancer Institute and...Zhejiang Hisun Pharmaceutical Co. Ltd.UnknownAbdominal InfectionChina
-
Milton S. Hershey Medical CenterWithdrawnSepsis | Septic Shock | Multiple Organ Dysfunction | Intra-abdominal Sepsis
-
University of CalgaryAlberta Health servicesRecruitingAbdominal Sepsis | Abdominal InfectionCanada
-
Cairo UniversityCompleted
-
Nanjing PLA General HospitalCompletedIntra-abdominal Perforation
-
Universidad Autonoma de San Luis PotosíUnknown
-
Jinling Hospital, ChinaCompletedDigestive System Fistula | Appendicitis | Abdominal Abscess | Pancreatitis | Severe SepsisChina
-
Aristotle University Of ThessalonikiCompleted
-
Sociedade Brasileira de Atendimento Integrado ao...UnknownAbdominal Trauma | Abdominal Sepsis | Abdominal Compartment Syndrome
-
Duke UniversityRecruitingSepsis | Surgery | Intra-abdominal Infection | Diet, Healthy | Enteral Feeding | Intensive Care | Nutrition | Abdominal Trauma | Food | Ischemic Bowel | Vascular | Penetrating Abdominal Trauma | OralUnited States
Clinical Trials on Management
-
Northwestern UniversityNorthShore University HealthSystemRecruitingBenign Prostatic HyperplasiaUnited States
-
First Affiliated Hospital Xi'an Jiaotong UniversityCompleted
-
University Hospitals, LeicesterCompletedChronic Kidney DiseaseUnited Kingdom
-
Johns Hopkins UniversityJohns Hopkins Community PhysiciansWithdrawnSubstance-related DisorderUnited States
-
University of LeedsNational Institute for Health Research, United KingdomUnknownCongestive Heart Failure | Pacemaker ComplicationUnited Kingdom
-
Dallas VA Medical CenterCompletedColorectal Surgery | Surgical Wound InfectionsUnited States
-
University of OklahomaNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruitingDiabetes Mellitus | Cholesterol, Elevated
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedActive Second StageFrance
-
Children's Hospital of Eastern OntarioTerminated
-
Ain Shams Maternity HospitalAin Shams UniversityUnknownPreterm Premature Rupture of MembranesEgypt